Head to Head Study of Anti-VEGF Treatment.

NCT02577107 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Macular Degeneration

Interventions

DRUG: ranibizumab
DRUG: Conbercept

Sponsor

Novartis Pharmaceuticals